Related Experiment Video
Updated: Apr 25, 2026

Differential Scanning Calorimetry — A Method for Assessing the Thermal Stability and Conformation of Protein Antigen
Published on: March 4, 2017
Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine
Rahul Misra1, Siddhant Sharma2, Manjit Haer2
1Vaccine CMC Development and Supply, Analytical Sciences, Sanofi, Toronto, M2R 3T4, Canada. Rahul.misra@sanofi.com.
Purpose:
Nano differential scanning fluorimetry (nano-DSF) is a high-throughput screening technique that simultaneously assesses colloidal and conformational stabilities of protein antigens by monitoring their thermal unfolding patterns and aggregation behaviors. It offers significant advantages over conventional approaches used for thermal stability assessment of proteins, such as Differential Scanning Calorimetry (DSC).
Methods:
The present study evaluates the thermal unfolding and aggregation behavior of an in-house recombinant COVID-19 SARS-CoV-2 spike protein variant and its engineered prototype as vaccine antigens. We investigated their structural integrity and colloidal behavior under well-defined physical conditions such as pH transition, addition of excipients, and at different manufacturing stages.
Results:
Changes in melting and aggregation temperatures (Tm and Tagg) were assessed as indicators of the structural integrity and colloidal stability of spike protein variants.
Conclusion:
We have shown how nano-DSF technology can be useful in developing a stable formulation which can minimize conformational changes and aggregation. Our study highlights the potential of nano-DSF for process optimization and as an advanced preliminary decision-making tool to be used before initiating long-term stability studies in biopharmaceutical R&D.
More Related Videos
07:22How to Stabilize Protein: Stability Screens for Thermal Shift Assays and Nano Differential Scanning Fluorimetry in the Virus-X Project
Published on: February 11, 2019
08:48Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022